Form 4: Voyager Therapeutics Chief Legal Officer Sells Shares to Cover Tax Obligations

Jacquelyn Fahey Sandell, Chief Legal Officer of Voyager Therapeutics, sold 5,999 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Jacquelyn Fahey Sandell, the Chief Legal Officer of Voyager Therapeutics, sold 5,999 shares of common stock on October 2, 2024.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units on October 1, 2024.
• The shares were sold at a weighted average price of $5.82, with individual transactions ranging from $5.77 to $5.88.
• Following the transaction, Sandell directly owns 86,001 shares of Voyager Therapeutics common stock.

Sentiment

Score: 5

Explanation: This is a neutral event. An executive selling shares to cover taxes is a normal occurrence and doesn't necessarily reflect a positive or negative outlook on the company.

Industry Context

This is a routine Form 4 filing, reflecting a company officer selling shares to cover tax obligations. Such transactions are common and don't necessarily indicate a change in the officer's confidence in the company.

Stakeholder Impact

• The sale of shares may have a minimal impact on shareholders due to the relatively small volume of shares sold.

Key Dates